Taylor Swift, a pop star with sufficient power to move mountains, succeeded in moving an equally resolute object last year: Apple Music’s position on paying royalties to
Tag: patents
“All Prior Art” algorithm won’t stop bad patents or actors
Stopping new inventions dead in their tracks by making them “automatically” unpatentable might sound like a good idea to some. However, programming a computer to
“Building an Innovation Economy” is focus of latest Hoover IP² event
IP², an initiative of the Hoover Institution at Stanford University, last week hosted a more than 60 IP scholars, economists and practitioners to hear and challenge research
The impact of higher patent licensing hurdles may not be fully understood
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
Jury awards Merck $200M in patent damages, 10% of what it had sought
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
“Secrets” is required reading for informed managers and investors
In an information age that worships data and transparency, the trade or business secret has never been more valuable. “Secrets” is an essential guide to
EU study: IP holders have 29% more revenue per employee; pay 20% higher wages
Companies that own intellectual property rights typically generate 29% higher revenue per employee, have about six times as many employees, and pay wages that are
Pro-Patent Momentum on the Rise?
Five recent articles challenge anti-IP myths driven by tech cos. Does the business media have the courage to follow? For decades patent enforcement has been
When NPR Attacks Patents: Stories are Long on Drama, Short on Truth
“When Patents Attack… Part II!” revisits old ground about bad IP actors by relying on half-truths and high drama. “This American Life,” an entertaining weekly
Silicon Valley: Too Big to Fail, or Too Big Not To?
Am I seeing things or is the innovation capitol becoming less hospitable to really new ideas and strong patents? Are Silicon Valley’s guiding lights still
IBM’s Huge Lead in Patents: Under the Microscope
Big Blue may be caught in its image as the perennial patents-received leader, for better or worse. Obtaining large numbers of patents is often more
ipcloseup.com 